The report provides a detailed analysis essential for establishing a dydrogesterone production plant. It encompasses all critical aspects necessary for dydrogesterone production, including the cost of dydrogesterone production, dydrogesterone plant cost, dydrogesterone production costs, and the overall dydrogesterone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a dydrogesterone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dydrogesterone is a synthetic hormone used primarily in the treatment of various gynaecological and reproductive health conditions. It is commonly prescribed to manage irregular menstrual cycles, alleviate symptoms of premenstrual syndrome (PMS), and treat conditions such as endometriosis and infertility. It is often used in hormone replacement therapy for women experiencing menopause, helping to balance hormone levels and reduce related symptoms. It is also prescribed for women with a history of recurrent miscarriages, as it supports pregnancy by stabilising the uterine lining. Additionally, dydrogesterone is used in assisted reproduction treatments, such as in vitro fertilisation (IVF), to support early pregnancy. It also plays an important role in treating dysfunctional uterine bleeding and providing relief from menstrual disorders. It is often preferred over other progestins due to its ability to mimic natural progesterone, making it effective and well tolerated.
The primary factor driving the market for dydrogesterone is its demand as a synthetic progestational hormone for treating reproductive health conditions. Its application as an oral drug in managing menstrual disorders and treating endometriosis significantly boosts its demand in the pharmaceutical sector. Its use in hormone replacement therapy (HRT) to balance progesterone levels during menopause further supports demand in the healthcare sector. Its involvement in fertility treatments to maintain the uterine lining and prevent miscarriage promotes its adoption in gynaecology clinics.
Rising awareness regarding reproductive health, increasing hormonal imbalance cases, and delayed pregnancies contribute to higher consumption across hospitals and speciality clinics. Manufacturing efficiency, regulatory compliance, reliable supplier networks, and stable distribution channels significantly impact industrial dydrogesterone procurement globally. Raw material availability, regulatory approvals, quality standards, and patent considerations also influence procurement practices.
Raw Material for Dydrogesterone Production
According to the dydrogesterone production plant project report, the major raw material used in dydrogesterone production is lumisterol (9beta,10alpha-ergosta-5,7,22-trien-3beta-ol).
Production Process of Dydrogesterone
The extensive dydrogesterone production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of dydrogesterone begins with the preparation of lumisterol derived from ultraviolet-irradiated ergosterol. The compound then undergoes multistep synthesis beginning with oxidation to modify its structure. It is subsequently subjected to isomerisation, followed by lithium reduction. The side chain is cleaved through ozonolysis, and a final zinc reduction step completes the synthesis, resulting in the formation of dydrogesterone.
Dydrogesterone is a synthetic progestational hormone belonging to the retrosteroid class and is a stereoisomer of natural progesterone. It appears as a white to light yellow crystalline solid that is practically insoluble in water but soluble in acetone and sparingly soluble in ethanol. The molecular formula is C21H28O2, and its molar mass is 312.45 g/mol. Its density is approximately 1.07 g/cm3. The melting point ranges between 168–173 degrees Celsius, and the boiling point is around 392 degrees Celsius. The compound should be stored at 2–8 degrees Celsius to maintain stability. It does not inhibit ovulation and exhibits no androgenic, oestrogenic, anabolic, or corticoid activity. It may cause organ damage through prolonged exposure and is very toxic to aquatic life with long lasting effects. Appropriate protective equipment should be worn during handling.
